Menogaril
Alternative Names: 7 OMEN; Menogarol; NSC 269148; Tomosar; TUT 7; U 52047; UT 7Latest Information Update: 04 Jul 2006
At a glance
- Originator Pfizer
- Developer Pfizer; Taiho Pharmaceutical
- Class Anthracyclines; Cytostatic antibiotics; Nogalamucins
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Breast cancer; Cancer; Chronic lymphocytic leukaemia; Colorectal cancer; Malignant melanoma; Multiple myeloma; Myeloid leukaemia; Non-small cell lung cancer; Ovarian cancer; Prostate cancer
- Discontinued Lymphoma
Most Recent Events
- 04 Jul 2006 No development reported - Phase-I for Cancer in Canada (unspecified route)
- 04 Jul 2006 No development reported - Phase-II for Breast cancer in European Union (unspecified route)
- 04 Jul 2006 No development reported - Phase-II for Cancer in Japan (unspecified route)